# iShares Health Innovation Active ETF (BMED): ETF Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/bmed for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: IShares · Asset class: Equity - Strategy: Thematic · Inception: 2020-09-29 BMED focuses on total return by investing in the broad health sciences group of industries from R&D to production and distribution of medical supplies in different fields, including dental, optical or pharmaceuticals. It also involves healthcare providers including health facilities and hospitals or those providing related administrative, management or financial support. The fund reaches into non-human health (e.g., survival of plants and animals) such as firms that increase crop yields, taste, nutritional content or improve pet health. BMED will include firms with varying market-cap with b... ## Key Facts | Metric | Value | |---|---| | Price | $35.25 | | Expense Ratio | 0.77% | | Assets Under Management | $14.1M | | NAV | $35.20 | | Holdings Count | 57 | | Distribution Yield (TTM) | 0.23% | | Annual Distribution (TTM) | $0.08 /share | | Distribution Frequency | Irregular | | 52-Week Range | $27.25 – $35.67 | | Beta | 0.74 | ## Latest Distribution - Amount: $0.0812 /share - Ex-date: 2026-06-15 - Pay date: 2026-06-18 ## Frequently Asked Questions ### What does BMED invest in? BMED focuses on total return by investing in the broad health sciences group of industries from R&D to production and distribution of medical supplies in different fields, including dental, optical or pharmaceuticals. It also involves healthcare providers including health facilities and hospitals or those providing related administrative, management or financial support. The fund reaches into non-human health (e.g., survival of plants and animals) such as firms that increase crop yields, taste, nutritional content or improve pet health. BMED will include firms with varying market-cap with bias to small- and mid-caps that may include foreign non-USD-denominated securities. The fund may also hold REITs that own hospitals and IPOs. During temporary defensive periods, the fund may invest up to 100% of assets in liquid, short-term investments and can enter in credit default swaps for risk management. Prior to Oct. 10, 2024, the fund used Blackrock for branding purposes instead of iShares. ### What is the expense ratio of BMED? iShares Health Innovation Active ETF (BMED) charges an expense ratio of 0.77%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is BMED? iShares Health Innovation Active ETF (BMED) manages $14.1M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is BMED actively managed or an index fund? BMED's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy. ### When was BMED launched? iShares Health Innovation Active ETF (BMED) launched in September 2020 and is managed by IShares. ### How has BMED performed? BMED's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does BMED pay a dividend? iShares Health Innovation Active ETF (BMED) currently distributes little or no income. Trailing-twelve-month yield is 0.23%. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does BMED pay dividends? iShares Health Innovation Active ETF pays dividends Irregular. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is BMED's dividend yield? BMED's trailing-twelve-month yield is 0.23%, calculated from the sum of dividends over the past year divided by the current price. ### When is BMED's next ex-dividend date? The most recently announced ex-dividend date for BMED was 2026-06-15. The next ex-date typically follows Irregular; once announced it appears at the top of the dividend history table on this page. ### How much will BMED's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 0.77% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does BMED charge its expense ratio? The expense ratio is deducted in tiny daily slices from BMED's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does BMED cost more than a fund like VOO? BMED's strategy (current expense ratio 0.77%) is different from a broad-market index tracker like VOO, so its fee belongs to a different cohort. The Cost Verdict card above shows you where BMED sits within its own category, which is the comparison that actually matters. ### Are there cheaper alternatives to BMED? The Lower-Fee Alternatives card above lists ETFs following the same investment strategy as BMED (0.77%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/bmed - Distribution history: https://www.dividenddata.com/funds/bmed/dividend - Holdings & diversification: https://www.dividenddata.com/funds/bmed/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/bmed/expenses - Peer comparison: https://www.dividenddata.com/funds/bmed/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.